Evaluation of Hospital Pandemic Control Strategies of a Chinese Tertiary Care Hospital During the Late Phase of COVID-19 Pandemic

Author(s)

Wang D1, Dong T1, Yu D1, Chen Y2, Yuan L1, Tang Y1, Chen T1, Qian Z1, Chen W3
1Xiangya Hospital of Central South University, Changsha, Hunan, China, 2Changsha Normin Health Technology Ltd, Changsha, Hunan, China, 3University of Toronto, Toronto, ON, Canada

OBJECTIVES: To evaluate COVID-19 control strategies for optimizing medical service capacity and hospital revenue in Chinese tertiary care hospitals during the late phase of the COVID-19 pandemic.

METHODS: A decision-making tree model was constructed to simulate health services, hospital revenue, and expenditures for outpatients and inpatients under two control strategies: Strict control (tracking and quarantining exposed individuals) vs. Unblock (only isolating infected inpatients until virus clearance). The model simulated COVID-19 risks and subsequent medical services utilization and hospital revenue based on reported incidence rates of the fifth wave of COVID-19 infection in Hong Kong and the real-world hospital operation data of a Chinese tier III tertiary care hospital in 2021. Base case and sensitivity analyses were conducted using the constructed model with three-month time horizon.

RESULTS: The model predicted 18,904 infected patients (13,543 outpatients, 5,361 inpatients), and 1,331 infected hospital staff during the peak of the fifth wave of COVID-19. The unblock scenario could provide more services (31.6 times more for outpatient visits; 1.7 times more for inpatient days; 3.4% more for surgery volume) and generate more revenue (by ¥220.8 million) than the strict control scenario. Even with low incidence rates of COVID-19 infection, the unblock scenario showed higher medical service utilization (4.1% more for outpatient visits; 2.4% more for inpatient days) and more revenue generation (by ¥12.8 million) over 3-month simulation time.

CONCLUSIONS: Isolated management for inpatients with COVID-19 only is likely the strategy that can optimize medical service capacity and revenue generation in Chinese tertiary care hospitals during the late phase of COVID-19 pandemic.

Conference/Value in Health Info

2023-11, ISPOR Europe 2023, Copenhagen, Denmark

Value in Health, Volume 26, Issue 11, S2 (December 2023)

Code

EE332

Topic

Economic Evaluation

Disease

Infectious Disease (non-vaccine)

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×